In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lekoptin Drug Master File in Korea (Lekoptin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lekoptin. The MFDS reviews the Lekoptin KDMF as part of the drug registration process and uses the information provided in the Lekoptin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lekoptin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lekoptin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lekoptin suppliers with KDMF on PharmaCompass.